Smith et al. "Principles of Biochemistry: General Aspects" McGraw-Hill Book Co. p. 63, 1983. |
Old Primrose. "Principles of Gene Manipulation: An Introduction to Genetic Engineering" Blackwell Scientific Publications, pp. 75-85, 134, 135, 238-241, 292, 1980. |
Paul, W.E. "Fundamental Immunology" Raven Press, p. 352 and 176, 1989. |
Akiyama, S.-I, et al., "Most Drugs that Reverse Multidrug Resistance Also Inhibit Photoaffinity Labeling of P-Glycoprotein by a Vinvlastine Analog," Molec. Pharm., 33:144 (1988). |
Borrebaeck, C.A.K. et al., "Critical appraisal of the in vitro immunization technology for the production of mouse and human monoclonal antibodies," Adv. Drug Devel. Rev., 2:143 (1988). |
Borrebaeck, "Human mAbs produced by primary in-vitro immunization," Immunol. Today, 9:355 (1988). |
Borrebaeck, "Strategy for the production of human monoclonal antibodies using in vitro activated B cells," J. Immunol. Meth., 123:157 (1989). |
Bhattacharya-Chattayee et al., "Idiotype Vaccines Against Human T Cell Leukemia," J. Immunol. Meth., 141:1398 (1988). |
Bird et al., "Single-Chain Antigen-Binding Proteins," Science, 242:423 (1988). |
Bruggeman, M. et al., "Comparison of the Effector Functions of Human Immunoglobulins Using A Matched Set of Chimeric Antibodies," J. Exp. Med., 166:1351 (1987). |
Charbit et al., "Versatility of a vector for expressing foreign polypeptides at the surface of Gram-negative bacteria," Gene, 70:181 (1988). |
Chaudhary, P.M. et al., "Expression and Activity of P-Glycoprotein, a Multidrug Efflux Pump, in Human Hematopoietic Stem Cells," Cell, 66:85 (1991). |
Chiang et al., "Direct cDNA Cloning of the Rearranged Immunoglobulin Variable Region," Biotechniques, 7:360 (1989). |
Choi et al., "Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection," PNAS (USA), 88:7386 (1991). |
Choi, K. et al., "An Altered Pattern of Cross-Resistance in Multidrug-Resistant Human Cells Results from Spontaneous Mutations in the mdr1 (P-Glycoprotein) Gene," Cell, 53:519 (1988). |
Cornwell, M.M. et al., "Increased Vinblastine Binding to Membrane Vesicles from Multidrug-resistant KB Cells," J. Biol. Chem., 261:7921 (1986). |
Foon, "Biological Response Modifiers: The New Immunotherapy," Cancer Res., 49:1621 (1989). |
Ford, J.M., et al., "Pharmacology of Drugs That Alter Multidrug Resistance in Cancer," Pharm. Rev., 42:155 (1990). |
Gathura, J.K. et al., "In vitro immunization of rat spleen lymphocytes with Forssman glycosphingolipid antigen and the generation of a monoclonal antibody," J. Immunol. Meth., 137:95 (1991). |
Glockshuber et al., "A Comparison of Strategies to Stabilize Immunoglobulin F.sub.v -Fragments," Biochem, 29:1362 (1990). |
Hamada et al., Proceedings of the National Academy of Sciences, vol. 83, issued Oct. 1986, pp. 7785-7789. |
Hamada, H., et al., "Mouse-Human Chimeric Antibody against the Multidrug Transporter P-Glycoprotein," Cancer Res., 50:3167 (1990). |
Hoeffler et al., "In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes," Histochem. J., 18:597 (1986). |
Horio, M., et al., "ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells," PNAS (USA), 85:3580 (1988). |
Hsu et al., "Differential Overexpression of Three mdr Gene Family Members in Multidrug-resistant J774.2 Mouse Cells," J. Biochem. Molec. Biol., 264:12053 (1989). |
Huston et al., "Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli," PNAS (USA), 85:5879 (1988). |
Jones, P.T., et al., "Replacing the complementarity-determining regions in a human antibody with those from a mouse," Nature, 321:522 (1986). |
Kearney, J.F. et al., "A New Mouse Myeloma Cell Line That Has Lost Immunoglobulin Expression But Permits The Construction of Antibody-Secreting Hybrid Cell Lines," J. Immunol., 123:1548 (1979). |
Kohler et al., "Idiotypic Networks and Nature of Molecular Mimicry: an Overview," Meth. Enzymol., 178:3 (1989). |
Meyers et al., Cancer Research, vol. 49, No. 12, issued Jun. 15, 1989, pp. 3209-3214. |
Neyfakh, A.A., "Use of Fluorescent Dyes as Molecular Probes for the Study of Multidrug Resistance," Exp. Cell Res., 174:168 (1988). |
Nilsson, B.O. et al., "Intrasplenic immunization with minute amounts of antigen," Immunol. Today, 11:10 (1990). |
Nolan et al., "Bifunctional antibodies: concept, production and applications," Biochim. Biophys. Acta, 1040:1 (1990). |
Orlandi, R. et al., "Cloning immunoglobulin variable domains for expression by the polymerase chain reaction," PNAS (USA), 86:3833 (1989). |
Pauwels, R., "Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds," J. Virol. Meth. 20:309 (1988). |
Pearson, J.W. et al., J. Natl. Cancer Inst., 83:1386 (1991). |
Pollack, B. et al., "The Production of Human Monoclonal Antibodies by In Vitro Immunization," Lab. Meth. Immunol., 1:51 (1990). |
Queen, C. et al., "A humanized antibody that binds to the interleukin 2 receptor," PNAS (USA), 86:10029 (1989). |
Reichmann, L. et al., "Reshaping human antibodies for therapy," Nature, 332:323 (1988). |
Schinkel et al., "Characterization of the Human MDR3 P-Glycoprotein and Its Recognition by P-Glycoprotein-specific Monoclonal Antibodies," Cancer Res., 51:2628 (1991). |
Songsivilai et al., "Bispecific antibody: a tool for diagnosis and treatment of disease," Clin. Exp. Immunol., 79:315 (1990). |
Tamai, I., "Competitive Interaction of Cyclosporins with the Vinca Alkaloid-binding Site of P-glycoprotein in Multidrug-resistant Cells," J. Biochem. Molec. Biol., 265:16509 (1990). |
Tsuruo, T. et al., "Inhibition of Multidrug-resistant Human Tumor Growth in Athymic Mice by Anti-P-glycoprotein Monoclonal Antibodies," Jpn. J. Cancer Res., 80:627 (1989). |
Vaux, D., et al., "On the Use of In Vitro Immunization for the Production of Monoclonal Antibodies," Technique (Phila.), 2:72 (1990). |
Verhoeyen, M. et al., "Reshaping Human Antibodies: Grafting an Antilysozyme Activity," Science, 239:1534 (1988). |
Winter, G. et al., "Man-made antibodies," Nature, 349:293 (1991). |
Young et al., "Dissection of Mycobacterium tuberculosis antigens using recombinant DNA," PNAS (USA), 82:2583 (1985). |
Borrebaeck, Antibody Engineering, 103 (1992). |
Broxterman et al., Biochem. Pharm., 37:2389-92 (1988). |
Burgess et al., Journal of Cell Biology, 111:2129 (1990). |
Cenciarelli, C. et al., "Characterization by Somatic Cell Genetics of a Monoclonal Antibody to the MDR1 Gene Product(P-Glycoprotein): Determination of P-Glycoprotein Expression in Multi-Drug Resistant KB and CEM Cell Variants," Int. J. Cancer, 47:533 (1991). |
Co et al., Nature, 351:501-502 (1991). |
Dillman et al., Annals of Internal. Med., 111(7):592 (1989). |
Georges et al., PNAS (USA), 87:152-56(1990). |
Georges et al., Abstract, Posner Session A, Amer. Assoc. Cancer Res., Mar. 11, 1991. |
Gilles et al., Human Antibod. Hybridonas, 1(1):47 (1990). |
Heike et al., Jpn.J.Cancer Res., 81:1155-61 (1990). |
Hird et al., Genes and Cancer, 183 (1990). |
Hoogenboom et al., Nucleic Acids Research, vol. 19, No. 15., 4133-4137 (1991). |
Kuwarzuru et al., Cancer, vol. 66, No. 5, issued Sep. 1, 1990, pp. 868-873. |
Lazar et al., Molecular and Cellular Biology 8(3), 1247 (1988). |
McCafferty et al., Nature, vol. 348, issued Dec. 6, 1990, pp. 552-554. |
Mechetner et al., Proc. Natl. Acad. Sci. USA, 89:5824-5828 (1992). |
Meyers et al., Cancer Research, vol. 49, No. 12, issued Jun. 15, 1989, pp. 3209-3214. |
O'Brien, J.P. et al. et al., Proc. Amer. Assoc. Cancer Res., 30:Abs 2114 (1989). |
Rittman-Grauer, Proc. Amer. Assoc. Cancer Res., 31:Abs. 2663 (1990). |
Shen et al., Molecular and Celluar Biology, vol. 6, No. 10, issued Nov. 1986, pp. 4039-4045. |
Tao et al., Journal of Immunology 143, 2595 (1989). |
Thorpe, Monoclonal Antibodies '84:Biological and Clinincal Applications, published 1985, pp. 475-506. |
Trail et al., "Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates," Science, 261:212-215(1993). |
Van Duk et al., Int.J. Cancer, 44:738-743 (1989). |
Waldmann, Science 252, 1657 (1991). |